Lyrical Asset Management LP Has $231.62 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Lyrical Asset Management LP grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.0% in the fourth quarter, HoldingsChannel reports. The fund owned 771,691 shares of the company’s stock after acquiring an additional 177 shares during the period. HCA Healthcare makes up 3.5% of Lyrical Asset Management LP’s portfolio, making the stock its 13th largest position. Lyrical Asset Management LP’s holdings in HCA Healthcare were worth $231,623,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HCA. Wedbush Securities Inc. lifted its position in HCA Healthcare by 19.0% during the 4th quarter. Wedbush Securities Inc. now owns 794 shares of the company’s stock worth $238,000 after buying an additional 127 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in HCA Healthcare by 14.3% during the fourth quarter. Envestnet Asset Management Inc. now owns 209,687 shares of the company’s stock valued at $62,938,000 after purchasing an additional 26,208 shares during the last quarter. Investidor Profissional Gestao de Recursos Ltda. acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $235,000. Dynamic Technology Lab Private Ltd bought a new position in shares of HCA Healthcare in the fourth quarter valued at $540,000. Finally, Oarsman Capital Inc. raised its position in HCA Healthcare by 21.7% during the fourth quarter. Oarsman Capital Inc. now owns 286 shares of the company’s stock worth $86,000 after acquiring an additional 51 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on HCA shares. Bank of America dropped their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Morgan Stanley cut their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. Barclays decreased their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Finally, Royal Bank of Canada decreased their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Trading Down 4.8 %

Shares of HCA Healthcare stock opened at $332.53 on Friday. The firm’s 50-day moving average price is $327.23 and its two-hundred day moving average price is $339.47. The company has a market capitalization of $81.87 billion, a price-to-earnings ratio of 15.14, a PEG ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the company earned $5.90 earnings per share. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a $0.72 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date was Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.